# Sequential and Hybrid Therapies for H Pylori Infection

> **NCT01085786** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 240 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** 14-day sequential treatment
- **DRUG:** 14-day hybrid treatment

## Key facts

- **NCT ID:** NCT01085786
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01085786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01085786, "Sequential and Hybrid Therapies for H Pylori Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01085786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*